'김갑성' 기자의 전체기사
-
Olympus Announces Distribution Partnership with MacroLux…
WESTBOROUGH, Mass., Sept. 4, 2025 -- Olympus Corp., a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today an exclusive global distribution agreement with MacroLux Medical Technology Co., Ltd. to distribute single-use urology products. The agreement includes multiple single-use cystoscopes, ureteroscopes and suction access sheaths. These devices are used to access and visualize the bladder and urinary tract to diagnose and treat urinary diseases and disorders such as kidney stones. "We ar
- 김갑성 기자
- 2025-09-04 22:12
-
Alma, a Sisram Medical Company, Announces Strategic Colla…
HONG KONG, Sept. 4, 2025 -- Sisram Medical (1696.HK), a global leading innovator and provider of holistic medical aesthetic solutions, today announced a strategic collaboration between its subsidiary Alma, a global leader in energy-based medical and aesthetic solutions, and Jamie Sherrill ("Nurse Jamie"), the internationally recognized celebrity skin-care expert, entrepreneur, and media personality. The partnership marks an important step in Alma's strategy to expand consumer engagement and strengthen its leadership in premium aesthetic technologies. With more than two decade
- 김갑성 기자
- 2025-09-04 22:00
-
Accro Bioscience to Present Phase II Data of AC-201 for Plaqu…
NEW YORK and SUZHOU, China, Sept. 4, 2025 -- Accro Bioscience (Accropeutics), a clinical-stage biotech company focused on molecular mechanisms of regulated cell death and related pathogenesis in human diseases, today announced that it will present results from a Phase II clinical study evaluating AC-201, an oral, selective TYK2/JAK1 Inhibitor, in moderate-to-severe plaque psoriasis, at the European Academy of Dermatology & Venereology (EADV) Congress, being held September 17-20th, in Paris. Details of the presentation are as follows:Abstract Type: Oral Presentation in the Late Brea
- 김갑성 기자
- 2025-09-04 20:24
-
Halia Therapeutics to Participate in the Morgan Stanley 23rd A…
LEHI, Utah, Sept. 4, 2025 -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class anti-inflammatory therapies, today announced that the Company plans to participate in the Morgan Stanley 23rd Annual Global Healthcare Conference. Jared Bearss, Chief Operating Officer of Halia, will provide a business overview presentation on Tuesday, September 9, 2025 at 7:00 am ET. About Halia Therapeutics Halia Therapeutics is a clinical-stage biopharmaceutical company focused on treating the root causes of inflammation. Leveraging geneti
- 김갑성 기자
- 2025-09-04 20:00
-
Angel Yeast Protein Receives U.S. GRAS Certification, Opening t…
SHANGHAI, Sept. 4, 2025 -- Angel Yeast (SH600298), a leading global provider of yeast and fermentation-based ingredients, announced today that its proprietary yeast protein, AngeoPro, has been granted Generally Recognized as Safe (GRAS) status by the U.S. Food and Drug Administration (FDA). The designation not only affirms the safety of the product but also marks a significant milestone in Angel Yeast's effort to expand the role of sustainable yeast protein in the global food supply. Positioned as a solution to challenges such as food security, climate change, and the
- 김갑성 기자
- 2025-09-04 20:00
-
Sentec Receives FDA Clearance for LuMon™ Electrical Imped…
The LuMon™ System is also CE-marked under EU MDR and registered with TGA in Australia. LINCOLN, R.I., Sept. 4, 2025 -- Sentec, a global leader in non-invasive patient monitoring, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its LuMon™ Electrical Impedance Tomography (EIT) system for premature infant, infant, adolescent, and adult patients—making it the first EIT technology in the United States available for premature infants and for spontaneously breathing patients. The LuMon™ EIT System delivers functional lu
- 김갑성 기자
- 2025-09-04 19:00
-
UNSW and NeuRA Lead New Study to Explore How ReNeuWell® A…
SYDNEY, Sept. 4, 2025 -- A clinical trial is being launched by researchers from UNSW and Neuroscience Research Australian (NeuRA) for a new app called ReNeuWell®, based on a scientifically validated measure of wellbeing. The application has been designed in collaboration with a research team led by A/Professor Justine Gatt from UNSW's School of Psychology and NeuRA. It uses the COMPAS-W Wellbeing Scale - which measures both subjective and psychological wellbeing, a scale developed by A/Prof Justine Gatt and that has been validated in neuroscience. Miroma Project Factory, sp
- 김갑성 기자
- 2025-09-04 06:23
-
Global Times: China's V-Day commemorations showcase re…
BEIJING, Sept. 4, 2025 -- China held a massive military parade in central Beijing on Wednesday to mark the 80th anniversary of its victory in the Chinese People's War of Resistance against Japanese Aggression and the World Anti-Fascist War, pledging the country's commitment to peaceful development in a world still fraught with turbulence and uncertainties. President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, oversaw the parade and reviewed the troops. Standing beside Xi on Tian'anmen Rostru
- 김갑성 기자
- 2025-09-04 00:05
-
Illumina® Protein Prep launches to drive greater proteomic in…
[ 메디채널 김갑성 기자 ] Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease Following early access program, customers commend scale, high consistency, and easy sample to insights workflow Launch follows Illumina's announcement of agreement to acquire SomaLogic SAN DIEGO, Sept. 3, 2025 -- Illumina Inc. (NASDAQ: ILMN) today announced the launch of Illumina Protein Prep, an assay introducing superior performance for next-generation sequencing (NGS) based proteomics discove
- 김갑성 기자
- 2025-09-03 21:15
-
Viettel's High-Tech Military Equipment Makes Debut at Vietnam…
HANOI, Vietnam, Sept. 3, 2025 -- Viettel Group, Vietnam's largest telecommunications company and a pioneer in defense technology, unveiled a wide range of high-tech military equipment during the grand military parade commemorating the 80th anniversary of the August Revolution and National Day. This marks the first time Viettel's domestically developed weapons were showcased at Ba Dinh Square, highlighting its unique role as the only enterprise in Vietnam that both leads the telecom market and independently researches and manufactures advanced defense systems. Viettel's display
- 김갑성 기자
- 2025-09-03 21:10
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-19_SUN
- Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting 15:00
- Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia 14:00
- From Wellbeing to Academics: Why HK Parents Are Hitting Pause on Kids' Social Media and Device Use 13:00
- 내면의 조화를 발견하세요: '원더풀 인도네시아 웰니스 페스티벌 2025' 개최 01:50
- 제2회 마나르 아부다비 출품 작가 명단 공개 00:48
- 중국-피지 어업 협력, 섬나라 경제 활력 끌어올리다 00:00
2025-10-18_SAT
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 19일 16시 40분